[Use of hydergine in acute ischemic pathology of the brain].
D000086:Acetazolamide / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000628:Aminophylline / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications; D002245:Carbon Dioxide / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D005260:Female; D005602:France; D005858:Germany; D006339:Heart Rate; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D007558:Italy; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use
D009539:Nicotinic Acids; D002245:Carbon Dioxide; D000628:Aminophylline; D004877:Ergoloid Mesylates; D010208:Papaverine; D000086:Acetazolamide
El uso de la Hydergina en la patología isquémica aguda del encéfalo.